Примери за използване на Member state committee на Английски и техните преводи на Български
{-}
-
Colloquial
-
Official
-
Medicine
-
Ecclesiastic
-
Ecclesiastic
-
Computer
The Member State Committee.
If any amendments are proposed,the issue is referred to the Member State Committee.
The Member State Committee.
The Member States shall appoint one member each to the Member State Committee.
The Member State Committee.
If ECHA receives proposals for amendment, it will refer the draft decision to the Member State Committee.
The Member State Committee.
Where ECHA receives no proposals for amendment from the Member States, it takes the decision without further need for involvement of the Member State Committee.
Member State Committee- ECHA.
The proposals and the comments are forwarded to the Member State Committee(MSC) to agree on the identification as an SVHC.
The Member State Committee shall take any comments received into account.
When the Members States and ECHA do not propose amendments to the draft decision,ECHA can take the final decision accordingly without the involvement of the Member State Committee.
In addition, the Member State Committee issues an opinion on the recommendation before it is submitted to the European Commission.
Transitional arrangements and, where relevant, exemptions and review periods to the European Commission,taking into account the opinion of the Member State Committee.
The Member State Committee prepares its opinion on the draft recommendation taking into account the comments received during the public consultation.
Comments relevant for the identification of the substance as an SVHC will be forwarded to the Member State Committee(MSC) which will assess whether the substance should be identified as an SVHC.
The Member State Committee will prepare an opinion on ECHA's draft recommendation taking into account the comments received during the public consultation.
Upon receipt of comments from another Member State or on its own initiative,the Agency shall refer the dossier to the Member State Committee within 15 days of the end of the 30-day period referred to in paragraph 4.
If the Member State Committee fails to reach unanimous agreement, the Commission should adopt a decision in accordance with a Committee procedure.
If the Member State competent authorities do not propose any amendments to the draft decision, or if the Member State Committee has unanimously agreed on a draft decision, ECHA will issue the adopted decision.
The Member State Committee is responsible for resolving potential divergences of opinions on draft decisions proposed by the Agency or the Member States. .
The Agency shallrefer a draft decision, together with any amendments proposed, to the Member State Committee within 15 days of the end of the 30-day period referred to in paragraph 2.
If the Member State Committee fails to reach unanimous agreement, the Commission shall prepare a draft decision to be taken in accordance with the procedure referred to in Article 133(3).
In accordance with Regulation(EU) No 182/2011 this analysis will be submitted to the Member State Committee and shall be made available to the Parliament and the Council through the register of committee proceedings.
The Member State Committee will assess whether the draft decision should be revised and seeks agreement on the draft decision taking the comments of the registrant into account.
For substance evaluation, the substance is placed on a list of substances to be evaluated which is called the community rolling action plan(CoRAP) andis adopted on the basis of the opinion of the Member State Committee.
If, within 60 days of the referral, the Member State Committee reaches a unanimous agreement on the draft decision, the Agency shall take the decision accordingly.
Based on the comments received during the public consultation, the proposals are discussed in the respective Committees(Risk AssessmentCommittee for CLH and restrictions, the Committee for Socio-economic Analysis for restrictions, and the Member State Committee for SVHCs).
If, within 60 days of the referral, the Member State Committee reaches unanimous agreement, the Member States concerned shall adopt substances for evaluation accordingly.
Prior to a decision to include substances in Annex XIV, the Agency shall,taking into account the opinion of the Member State Committee, recommend priority substances to be included specifying for each substance the items set out in paragraph 1.